Organovo Provides Market Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, shares rise
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
Organovo (ONVO) Updates Investor FAQ; Addresses Negative Market Commentary, Filing of Stock Shelf
March 13, 2015 10:35 AM EDTOrganovo Holdings (AMEX: ONVO) is positive Friday following a update on the current and expected market for its products, as well as financial positioning of the company. That announcement can be read here.
In addition, Organovo also updated the frequently asked questions (FAQ) portion of its website. The following are notable updates since the last update made on May 15,... More
Organovo (ONVO) Updates on Performance, Opportunities; Sees $100M+ Market for exVive3D
March 13, 2015 8:15 AM EDTOrganovo Holdings, Inc. (AMEX: ONVO), is providing the following market update:
Organovo remains extremely excited about the early commercial success of our exVive3D Human Liver Tissue and we continue to believe it has a strong commercial future in front of it. Nothing has changed from the Company's perspective, nor are we in possession of any new information that would dampen our optimism about the future of our exVive3D Human Liver Tissue or the... More
